Exodontia

Oral Cancer – Rapid Referral

Oral Cancer – Referral of Patients with Suspicious Lesions

The Pathway of Care shows how a patient with a (District General Hospital) and seen within 2 weeks (in the UK).

If the lesion is thought to be suspicious, then investigations, imaging ± biopsy are carried out.

The biopsy results are ‘fast-tracked’ and the patient would be seen with the histological results of the biopsy, investigations & imaging results at the MDT (Multi-Disciplinary Team) meeting (held in my area, down at Maidstone Hospital, Kent).

Kent_Medway_Cancer_Network_-_A_Pathway_of_Care_2-786x1145
Warning_Features_suggestive_of_Carcinoma-790x492
The suspicious features that the GDP should be aware of are listed here (high-lighted in yellow); these are in a box on the Rapid Referral Form. The suspicious features that the GDP should be aware of are listed here (high-lighted in yellow); these are in a box on the Rapid Referral Form.
The Pathway of Care shows how a patient with a (District General Hospital) and seen within 2 weeks (in the UK). If the lesion is thought to be suspicious, then investigations, imaging ± biopsy are carried out. The biopsy results are 'fast-tracked' and the patient would be seen with the histological results of the biopsy, investigations & imaging results at the MDT (Multi-Disciplinary Team) meeting (held in my area, down at Maidstone Hospital, Kent). The suspicious features that the GDP should be aware of are listed here (high-lighted in yellow); these are in a box on the Rapid Referral Form.
The Pathway of Care shows how a patient with a (District General Hospital) and seen within 2 weeks (in the UK).
If the lesion is thought to be suspicious, then investigations, imaging ± biopsy are carried out.
The biopsy results are ‘fast-tracked’ and the patient would be seen with the histological results of the biopsy, investigations & imaging results at the MDT (Multi-Disciplinary Team) meeting (held in my area, down at Maidstone Hospital, Kent).
The suspicious features that the GDP should be aware of are listed here (high-lighted in yellow); these are in a box on the Rapid Referral Form.
The Pathway of Care shows how a patient with a (District General Hospital) and seen within 2 weeks (in the UK). If the lesion is thought to be suspicious, then investigations, imaging ± biopsy are carried out. The biopsy results are 'fast-tracked' and the patient would be seen with the histological results of the biopsy, investigations & imaging results at the MDT (Multi-Disciplinary Team) meeting (held in my area, down at Maidstone Hospital, Kent). The suspicious features that the GDP should be aware of are listed here (high-lighted in yellow); these are in a box on the Rapid Referral Form.
The Pathway of Care shows how a patient with a (District General Hospital) and seen within 2 weeks (in the UK).
If the lesion is thought to be suspicious, then investigations, imaging ± biopsy are carried out.
The biopsy results are ‘fast-tracked’ and the patient would be seen with the histological results of the biopsy, investigations & imaging results at the MDT (Multi-Disciplinary Team) meeting (held in my area, down at Maidstone Hospital, Kent).
The suspicious features that the GDP should be aware of are listed here (high-lighted in yellow); these are in a box on the Rapid Referral Form.These are the referral forms for suspected neoplastic / mitotic lesions – these are filled out & sent electronically

When consulting with your patient it is important that you record clinical status, signs, symptoms, referral process & what information & advice you gave the patient both verbally & in writing.

Records should be kept In-line with authoritative and professional guidance.

A “best practice” Head & Neck referral A “best practice” Head & Neck referral
Good_Practice_Referral_Form_Template-1009x1463 Information given to a patient should cover:

  • What an urgent ‘Two Week’ referral is
  • Why the patient is being referred to a 2nd care cancer service
  • The percentage of urgent ‘Two Week’ referrals that are cancerous
  • Which 2nd care cancer service the patient is being referred to
  • How they will receive their appointment
  • The importance of attendance
  • Whether the patient can take someone with them
  • What type of tests / investigations that might be carried out & how long it will take to get results & a diagnosis
  • How to obtain further help & information about the type of oral cancer suspected

Patient_Information_Leaflet-1013x1406

Useful Articles & Websites

Cancer Research UK

Oral Cancer LDV

Clinical Knowledge Summaries

National Institute of Clinical Excellence

MacMillan Cancer Support

NICE Guidelines 2004. Healthcare Services for Head & Neck Cancers. Understanding NICE Guidance – Information for the Public

J Can Dent Assoc 2008. Biopsy & Histopathologic Diagnosis of Oral Premalignant & Malignant Lesions

BDJ 2010. Study of the Experience of Primary Care GDP’s in the detection & Management of Potentially Malignant Lesion. 1. Factors influencing detetction & the Decision to Refer

BDJ 2010. Study of the Experience of Primary Care GDP’s in the detection & Management of Potentially Malignant Lesion. 2. Mechanics of the Referral & Patient Communication

Dental Update 2011. Importance of Quality in Referral Letters Sent for Potentially Malignant Oral, Head & Neck Lesions

Head & Neck Cancer Guidelines 2011

BDJ 2015. Why Don’t Dentists Talk To Patients About Oral Cancer?

Dent Update 2016. Mouth Cancer for Clinicians Part 8. Referral

NICE Guidelines 2017. Head & Neck Cancer

BDJ 2018. Mouth Cancer – Presentation, Detection & Referral in Primary Dental Care

Dental Update 2020. Mouth Cancer – the Maxillofacial Surgeon’s perspective

Dental Update 2020. Mouth Cancer – What is it to Me & You